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https://doi.org/10.1016/j.celrep.2020.107627SUMMARYWhereas hundreds of cells in the mouse embryonic aorta transdifferentiate to hematopoietic cells, only very
few establish hematopoietic stem cell (HSC) identity at a single time point. The Gata2 transcription factor is
essential for HSC generation and function. In contrast to surface-marker-based cell isolation, Gata2-based
enrichment provides a direct link to the internal HSC regulatory network. Here, we use iterations of index-
sorting of Gata2-expressing intra-aortic hematopoietic cluster (IAHC) cells, single-cell transcriptomics,
and functional analyses to connect HSC identity to specific gene expression. Gata2-expressing IAHC cells
separate into 5 major transcriptomic clusters. Iterative analyses reveal refined CD31, cKit, and CD27 pheno-
typic parameters that associate specific molecular profiles in one cluster with distinct HSC and multipotent
progenitor function. Thus, by iterations of single-cell approaches, we identify the transcriptome of the first
functional HSCs as they emerge in the mouse embryo and localize them to aortic clusters containing 1–2
cells.INTRODUCTION
Hematopoietic stem cells (HSCs) arise through a developmental
fate process known as endothelial-to-hematopoietic transition
(EHT) (Dzierzak and Bigas, 2018; Dzierzak and Speck, 2008; Jaf-
fredo et al., 2005). EHT is best characterized by the emergence
of intra-aortic hematopoietic cluster (IAHC) cells within the
aorta-gonad-mesonephros (AGM) region that transdifferentiate
from specialized hemogenic endothelial cells (de Bruijn et al.,
2002; North et al., 2002; Yokomizo and Dzierzak, 2010; Zovein
et al., 2008). Between mouse embryonic day (E)10.5 and
E12.5, IAHCs contain HSCs, hematopoietic progenitor cells
(HPCs), and other hematopoietic cells (HCs). Time-lapse imag-
ing gave the first visual in vivo proof of EHT in the mouse and ze-
brafish embryonic aorta (Bertrand et al., 2010; Boisset et al.,
2010; Kissa and Herbomel, 2010). This transition involves
changes from an endothelial transcriptional program to a pro-
gram promoting HC identity, morphology, and function (Swiers
et al., 2013). Although the precise program directing the genera-
tion of HSCs during EHT is as yet unknown, important molecular
and physiological aspects of HSC generation are conserved be-
tween zebrafish, chick, Xenopus, mouse, and human (Ciau-Uitz
and Patient, 2019; Dzierzak and Bigas, 2018; Ivanovs et al.,
2017).This is an open access article under the CC BY-NQuantitation of IAHC cells in wholemouse embryos (Yokomizo
and Dzierzak, 2010) shows a peak of ~700 phenotypic (cKit-pos-
itive) HCs at E10.5. Multicolor lineage tracing shows that clusters
are polyclonal, with about 545 Vav+ nascent hematopoietic pro-
genitor/stem cells (HP/SCs) emerging between E11.5 and 14.5
to establish lifelong hematopoiesis (Ganuza et al., 2017b). How-
ever, in the E10.5 aorta at the time of embryo isolation, very few
of these cells function as bona fide HSCs (Kumaravelu et al.,
2002; Medvinsky and Dzierzak, 1996; M€uller et al., 1994), as
determined by direct in vivo transplantation and long-term he-
matopoietic reconstitution of adult recipients (a standard test
for HSC function and clinical relevance). Recent in vivo marking
methods question the precise role of phenotypic HSCs defined
by in vivo repopulating activity and, instead, suggest that multi-
potent progenitors are responsible for adult steady-state hema-
topoiesis (Busch et al., 2015; Pei et al., 2017; Rodriguez-Fraticelli
et al., 2018; Schoedel et al., 2016; Sun et al., 2014). Out of the
hundreds of IAHC cells in E10.5 embryos, colony-forming unit-
culture (CFU-C) studies show that about half (350) of the
cluster cells are HPCs (de Pater et al., 2013). Thus, the very
low frequency of HSCs in the IAHCs highlights the complexity
in programming HSC identity as defined by repopulating function
and raises the questions: what processes influence acquisition
of this rare HSC identity rather than the more abundant HPC orCell Reports 31, 107627, May 12, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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HSCs?
Many studies, including our own, have set out to describe the
genetic program of HC transdifferentiation from that of embry-
onic aortic endothelium. Published transcriptome databases
are available for phenotypically (surface marker) enriched endo-
thelial cells, hemogenic endothelial cells, transitioning cells,
IAHCs, and HP/SCs, at both the population and single-cell levels
(Baron et al., 2018; Li et al., 2014, 2017; Lichtinger et al., 2012;
McKinney-Freeman et al., 2012;Moignard et al., 2015; Solaimani
Kartalaei et al., 2015; Swiers et al., 2013; Zhou et al., 2016). How-
ever, no unique transcriptional profile has yet been ascribed to
AGM HSCs, since the HSC transcriptome is represented in the
single-cell datasets only at a very low frequency compared
with the high frequency of HPCs and HCs. Interestingly, all these
datasets show the upregulated expression of several hemato-
poietic (‘‘heptad’’) transcription factors (TFs) (Wilson et al.,
2010) during EHT, including Gata2, which is pivotal to HSC and
HPC generation.
Gata2 is required for generation of IAHCs and functional
HSCs (de Pater et al., 2013; Ling et al., 2004; Tsai et al.,
1994; Tsai and Orkin, 1997). Haploinsufficiency perturbs EHT
and the timing and quantitative generation of HSCs (de Pater
et al., 2013; Ling et al., 2004), and its overexpression blocks
HSC function (Guiu et al., 2013; Tipping et al., 2009). Our recent
demonstration of pulsatile Gata2 expression level changes in
aortic endothelial cells undergoing EHT (Eich et al., 2018) re-
veals a previously unexplored dynamic regulatory aspect in he-
matopoietic fate acquisition. Studies in other systems have
shown an unstable program of gene expression in cells as
they take on specific lineage fate. These include regulators nu-
clear factor kB (NF-kB), Hes, and Nanog, which show pulsatile
expression behavior in single cells (Abranches et al., 2014;
Chang et al., 2008; Cohen-Saidon et al., 2009; Huang, 2009;
Kueh et al., 2016; Lahav, 2004; Miyanari and Torres-Padilla,
2012; Purvis and Lahav, 2013; Ryu et al., 2016).
To date, transcriptomic analyses of HSCs have relied on
cell-surface-marker-mediated enrichments. As TFs are
responsible for promoting the expression of these markers,
hematopoietic identities may be better understood through
direct enrichment based on TF expression. Our previously
described Gata2Venus (G2V) mouse model reports real-time
transcription and protein expression of Gata2 in vivo without
affecting hematopoietic development or function (Kaimakis
et al., 2016). To understand whether the transcriptome of sin-
gle IAHC cells (Baron et al., 2018; Zhou et al., 2016) correlates
with hematopoietic function, and whether HSC identity is
based on specific combinations of genes and expression
levels, G2V embryos were used to examine IAHC cells by iter-
ative single-cell transcriptomics and functional analyses.
Here, we show that functional heterogeneity in highly enriched
single index-sorted IAHC cells expressing medium levels of
Gata2 (G2med) corresponds with heterogeneity in TF expres-
sion levels. Following this, we reveal that specific expression
levels of Gata2, cKit, and CD27 define all in vivo repopulating
HSCs and that HSCs localize to IAHCs containing 1–2 cells.
This iterative methodology captures the transcriptome of the
first functional HSCs and closely related HPCs and suggests2 Cell Reports 31, 107627, May 12, 2020a stochastic process of quantitative molecular states leading
to the establishment of HSC identity.
RESULTS
Specific Gata2 and cKit Levels Define All HSCs and the
Majority of Multipotent HPCs
Previously, we showed that Venus fluorescence faithfully reports
Gata2 expression in Gata2IRESVenus reporter (G2V) mice (Eich
et al., 2018; Kaimakis et al., 2016). In G2V embryos, the spatio-
temporal expression of Gata2 and the development of EHT
and HSC are normal. At E10.5, all HSCs and 70% of HPCs ex-
press G2med. Some HPCs are Gata2 negative (G2) or high
(G2hi) (Eich et al., 2018; Kaimakis et al., 2016), and mature
mast cells express the highest levels (Kauts et al., 2018; Tsai
and Orkin, 1997). To focus on the most potent Gata2-expressing
progenitors and HSCs, we followed a multi-pronged approach
combining the refinement of sorting gates and single-cell in-
dex-sorting with functional in vivo and in vitro assays.
G2medCD31+ckit+ IAHC cells (all IAHC cells co-express CD31
and cKit) were separated into low (G2lo) and intermediate
(G2int) Gata2 fractions and further partitioned into cKitlo
and cKithi fractions (Figure 1A). In vitro progenitor assays (Fig-
ure 1B) of the four fractions revealed that most HPCs were
distributed equally between the CD31+cKithiG2lo and -G2int
fractions at both E10 and E11. Whereas, at E10, few or no
CFU-Cs were found in the cKitlo fractions, these fractions
at E11 contained some CFU-Cs. Multipotent CFU-GEMMs
(colony forming unit-granulocyte-erythroid-macrophage-mega-
karyocytes) were highly enriched or exclusively found in the
CD31+cKithiG2lo and -G2int fractions (the latter containing slightly
more GEMMs) at both embryonic stages.
Index-sorted CD31+cKithiG2int (G2int) cells (Figures 1B and
1C) and CD31+cKit+G2hi (G2hi) cells (as control; Figure 1D)
were examined in single-cell CFU assays to test whether HPC
lineage potential was related to Gata2 level. After 9–11 days,
both G2int and G2hi cells produced CFU-GEMMs, -GMs (gran-
ulocyte-macrophages), -Gs (granulocytes), and -Ms (macro-
phages) (Figures 1Ci and 1Di; plating efficiency, 1:5–6 and
1:2–4, respectively). However, the proportion of GEMMs was
higher in the G2int fraction (22% versus 9%). The CFU-C type
arising from each single index-sorted cell was plotted against
log-normalized mean fluorescent intensities (MFIs) for G2
(Figures 1Ci and 1Di), cKit (Figures 1Cii and 1Dii), and CD31
(Figures 1Ciii and 1Diii). Cells that produced CFU-GMs
and -Gs were widely varying in levels of G2 expression (MFI =
842–8,315) compared to those that produced CFU-GEMMs
and -Ms (MFI = 850–4,845). The average MFI for cKit expres-
sion on G2int cells yielding CFU-GEMMs was significantly
higher than for cells yielding CFU-Gs (Figure 1Cii), and the
average MFI for cKit expression on G2hi cells yielding CFU-
GEMMs was significantly higher than for the other three CFU
types (Figure 1Dii). Both G2int and G2hi fractions contained
cells yielding CFU-GEMMs with a significantly higher average
CD31 MFI than that for cells yielding CFU-Gs (Figures 1Ciii
and 1Diii). Thus, themost immature HPCs are cKithi and CD31hi.
Examination of in vivo repopulating activity within the sorted
E11 IAHC fractions showed that, despite G2int containing slightly
Figure 1. The Most Immature AGM HPCs Are cKithiCD31hi
(A) Flow-cytometric dot plots of representative E11 G2V AGM cells analyzed for side scatter (SSC-A) and CD31 expression (left) and cKit and Gata2 (G2)
expression of CD31+ cells (right). Cell percentage (±SEM) within gated regions. Hi, high; lo, low; int, intermediate; med, medium (lo+int).
(B) Hematopoietic progenitor numbers per lineage per embryo equivalent (ee) of E10 (32–37 somite pairs, sp; n = 4; embryos/experiment: 4, 4, 4, and 4) and E11
(43–48 sp; n = 3; embryos/experiment: 3, 6, 5, and 7) sorted AGM fractions in the colony-forming unit-culture (CFU-C) assay. GEMM, granulocyte-erythroid-
macrophage-megakaryocyte; GM, granulocyte-macrophage; M, macrophage; G, granulocyte; BFU-E, burst-forming unit-erythroid. Error bars represent mean ±
SEM. For E10 GEMMs: *cKithiG2int versus cKitloG2lo/int. For E11 GEMMs: *cKithiG2lo versus cKitloG2lo/int, and **cKithiG2int versus cKitloG2lo/int. For E11 GMs:
*cKithiG2int versus cKitloG2lo/int.
(C and D) E11 G2V AGM single cells were sorted for (C) CD31+cKithiG2int (11 embryos, 41–47 sp) and (D) CD31+cKit+G2hi cells (20 embryos; 40–49 sp) and
deposited in methylcellulose. CFU-Cs were counted at days 9–11 (total CD31+cKithiG2int = 169; total CD31+cKit+G2hi = 105). Each CFU (individual dot) was
examined for colony type and plotted against log10-normalizedmean fluorescence intensities (MFIs) for expression of (Ci andDi) G2, (Cii and Dii) cKit, and (Ciii and
Diii) CD31. Red lines indicate mean ± SEM.
(E) HSC activity in sorted AGM fractions as measured by in vivo transplantation (peripheral blood donor chimerism at 4 months post-injection). Cell numbers
injected: for cKithiG2lo, 950–1963, 2.9–5.4 ee; for cKithiG2int, 912–2,048, 2.5–6.2 ee; for cKitloG2med, 4,530–12,523, 3.3–5.9 ee (42–50 sp; n = 4; embryos/
experiment: 7, 9, 12, and 14).
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provided HSC engraftment at 4 months post-transplantation
(Figure 1E). No HSCs were detected in the CD31+cKitloG2med
fraction (Figure 1E) or, aswe previously reported, in theG2hi frac-
tion (Eich et al., 2018).
Transcriptome Heterogeneity and Clustering of Single
CD31+cKithiG2med Cells
Considering that, at E11, all GEMMs were found in the G2lo,
Gint, and G2hi fractions and that HSCs are exclusively in the
G2lo and G2int fractions, we index-sorted CD31+cKithiG2med
(G2lo+G2int = G2med) IAHC cells and analyzed them by sin-
gle-cell RNA sequencing (RNA-seq) using SmartSeq2 (Picelli
et al., 2014). Out of 1,015 CD31+cKithiG2med cells, 968 passed
quality control (95%). Of note, the mapping of reads was per-
formed using a custom reference that included the mouse
genome, the sequence of Venus and External RNA Controls
Consortium (ERCC) sequences, allowing confirmation of theco-regulation of Gata2 and Venus expression levels (Fig-
ure S1A; correlation coefficient, 0.7). We obtained the SPRING
visualization (Weinreb et al., 2018) of the 968 cells and defined
11 clusters (L1.1–L1.11) using the Louvain method (Figure 2A;
Figure S1Bi). Datasets obtained from several biological sam-
ples, or analyzed on different days, integrated well and
showed no batch effect (Figure S1Bii). Hence, cell acquisition
parameters and results were consistent between experiments.
To investigate cluster composition, cells were colored accord-
ing to the expression of well-known hematopoietic (Figure 2B)
and endothelial (Figure 2C) genes as well as several pivotal he-
matopoietic TFs (heptad TFs; Figure 2D). In this way, we could
merge clusters to define 5 main groups of cells within our highly
enriched HSC population (Figure 2A). The endothelial-like cluster
(EC; L1.1 and L1.2) contained 335 cells expressing endothelial
genes such as Flk1 (VEGFR-2), Cdh5 (VE-cadherin), and AplnR.
Runx1, which would be expected to be expressed in all cells
(Bee et al., 2009), was downregulated in the EC when comparedCell Reports 31, 107627, May 12, 2020 3
Figure 2. Five Distinct Transcriptomic Clusters Are Defined by Single-Cell RNA Sequencing of Highly Enriched AGM HSCs
(A) SPRING visualization of merged Louvain clusters corresponding to 968 single CD31+cKithiG2med IAHC cells (n = 6 at E11, 27.6 G2V embryos, 41–49 somite
pairs; n = 1 at E10, 2.7G2V embryos, 33–34 sp). See Figure S1B for Louvain clustering. Five clusters emerge based on the cell-lineage expression characteristics
and hierarchical clustering distances. EC, endothelial-like cluster; HC1, hematopoietic cluster 1; HC2, hematopoietic cluster 2; UC1, unknown cluster 1; UC2,
unknown cluster 2.
(B–D) Cells were colored according to the expression of (B) hematopoietic markers, (C) endothelial markers, and (D) hematopoietic "heptad" transcription factors.
(E) Heatmap and hierarchical clustering of the dataset of 968 CD31+cKithiG2med index-sorted cells using endothelial-, pre-HSC-, and HSC-specific genes
(indicated on the left in red, blue, and green, respectively) obtained from a published dataset of phenotypically enriched endothelial cells, pre-HSCs (T1+T2), and
E12/E14 HSCs (Zhou et al., 2016). Louvain identity (L1.1 to L1.11) and merged clusters (EC, HC1, HC2, UC1, and UC2) are also indicated (top).
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529 cells (L1.7–L1.11) expressing well-known hematopoietic
marker genes such asCD41,CD45, PU.1, andGpr56. HCs could
be subdivided into HC1 (405 cells; L1.7 and L1.8) and HC2 (124
cells; L1.9–L1.11) cells, according to the expression of genes
such as VE-cadherin and Ly6a. Finally, two smaller unknown
clusters were defined: UC1 and UC2. UC1 contained 85 cells
(L1.5–L1.6) expressing some hematopoietic markers such as
CD45 and PU.1 and lacking expression of CD41, Gpr56, and
endothelial markers Flk1,Cdh5, andAplnR. Cells within this clus-
ter also expressed high levels of Runx1. UC2 contained 19 cells
(L1.3–L1.4) that expressed Gata2 consistently, although there
were too few cells for confident analysis. In a more detailed anal-
ysis of the expression of the heptad TFs, Gata2 showed some
heterogeneity in expression levels in all clusters except UC1, in
which it was downregulated (see Discussion). Tal1 also showed
heterogeneous expression in all clusters. Erg and Lmo2 were
downregulated in HC2. These data demonstrate heterogeneity
in heptad TF expression among the single cells of highly enriched4 Cell Reports 31, 107627, May 12, 2020HPCs andHSCs.While some cell clusters show consistent levels
of one TF, other TFs vary in expression within a cluster, suggest-
ing an unstable regulation and/or dynamic expression between
highly similar single cells.
We also calculated the similarity of each cell to the gene
expression profile of validated adult bone marrow HSCs using
hscScore (Hamey and Go¨ttgens, 2019) (Figure S1C). The cells
within HC1 obtained the highest score, suggesting that this
cluster most likely contains the HSC fraction. Our datasets
were further examined in the context of a published single-
cell dataset (Zhou et al., 2016) of phenotypically enriched
AGM endothelial cells, pre-HSCs (type 1 and type 2), and
E12 and E14 fetal liver HSCs. First, 3 groups of genes specif-
ically expressed in endothelial cells, pre-HSCs, and HSCs
were defined by comparing the different cell types represented
in the published dataset (Figure S1D). These genes were used
to cluster our dataset (Figure 2E). Our EC correlated well with
the endothelial profile. HC1 contained cells that expressed
both pre-HSC-specific genes (Procr) and HSC-specific genes
Figure 3. Index-Sorting Parameters Separate Transcriptomic Clusters andGuide Further Enrichment of Functional Hematopoietic Stem and
Multipotent Progenitor Cells
(A and B) Flow-cytometric plots showing (A) side-scatter (SSC-A) and CD31 expression and (B) cKit and Gata2 (G2) expression of the 968 index-sorted single
cells. The color of each cell indicates presence in specific clusters: EC (endothelial-like cluster, green), HC1 (hematopoietic cluster 1, blue), HC2 (hematopoietic
cluster 2, ochre), UC1 (unkown cluster 1, magenta), and UC2 (unkown cluster 2, rose).
(C) Hematopoietic progenitor number and type per embryo equivalent (ee) of bulk-sorted E11 IAHC cells (n = 4; 41–50 somite pairs, sp; embryos/experiment: 8, 8,
3, 8) corresponding to transcriptomic clusters, as determined by colony-forming unit-culture (CFU-C) assay. GEMM, granulocyte-erythroid-macrophage-
megakaryocyte; GM, granulocyte-macrophage; M, macrophage; G, granulocyte; BFU-E, burst-forming unit-erythroid. For GEMMs: *EC versus HC1; for GMs:
*EC versus HC1, and **UC1+2+HC2 versus EC. Mean ± SEM.
(D) HSC activity in sorted E11 IAHC cells (n = 5; 40–49 sp; embryos/experiment: 15, 14, 11, 8, and 19) corresponding to transcriptomic clusters by in vivo
transplantation. Each point indicates percentage of donor-derived cells in peripheral blood of recipients at 4 months post-injection. Cell numbers injected: for
HC1, 721–2,811, 4.8–8 ee; for EC, 5,654–14,208, 4.7–8.1 ee; for UC1+2+HC2, 1,312–2,828, 4.8–8.4 ee. Black line indicates mean.
(E) In (Ei), cytometric gates were used for sorting HC1 cells from E11 G2V IAHCs (16.7 embryos, 41–49 sp). Single cells deposited for CFU-Cs were counted at
12 days (total CFU-Cs = 86). Each CFU (individual dot) was examined for colony type and plotted against log10-normalized mean fluorescence intensities (MFIs)
for (Eii) G2, (Eiii) cKit, and (Eiv) CD31 expression. GEMM, granulocyte-erythroid-macrophage-megakaryocyte; GM, granulocyte-macrophage; G, granulocyte; M,
macrophage. Red lines indicate mean ± SEM.
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expressed predominantly only HSC-specific genes (mainly
cells within L1.8). HC2 represented a more mature hematopoi-
etic profile where cells expressed all HSC-specific and no
pre-HSC-specific genes. UC1 had some endothelial and he-
matopoietic features and expressed mature hematopoietic
genes, including Cd53, Cd84/SLAM, Mndal/myeloid, and
Sp100/PML; almost no pre-HSC-specific genes; and a subset
of endothelial-specific genes (Pmp22, Anxa2, Anxa3, Ophn1,
Marcks, and Tcf4).Phenotypic Characteristics Derived from Index-Sorting
Guide Further Enrichment of Multipotent HCs
To examine whether the 5 transcriptomic clusters of CD31+
cKithiG2med cells correspond to specific hematopoietic activ-
ities, index-sorting data were analyzed for phenotypic character-
istics that would provide for cluster-distinct cell isolation. EC
cells were CD31hi and side-scatter high (SSChi), UC1+UC2+HC2
cells were CD31lo, and HC1 cells were CD31hi and SSClo (Fig-
ure 3A). No clear further separation was observed within the
cKithi fraction (Figure 3B), although HC1 cells expressed higherCell Reports 31, 107627, May 12, 2020 5
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variable levels. Based on these new sorting parameters
(CD31hiSSChi, CD31lo, and CD31hiSSClo), three fractions were
sorted and tested in vitro for CFU-C formation and in vivo for
long-term HSC repopulation.
No CFU-Cs were generated from EC cells (CD31hiSSChi; Fig-
ure 3C) as expected. CD31locKithiG2med cells (UC1+UC2+HC2)
contained 50 CFU-Cs per embryo equivalent (ee) of various
CFU-C types. CD31hiSSClocKithiG2med cells (HC1) contained
30 CFU-Cs per ee. Interestingly, a trend of more multipotent
HPCs (7 GEMMs per ee), fewer bi-potent HPCs (17 GMs per
ee), and few or no unipotent HPCs (Gs and burst-forming unit-
erythroid [BFU-Es]) was detected in HC1 cells as compared to
the UC1+UC2+HC2 cells (5 GEMMs per ee and 24.5 GMs per
ee). The results of long-term in vivo transplantations showed
that the HC1 fraction contains all HSCs (Figure 3D) and is 10.5-
fold enriched compared to the CD31+cKit+G2med fraction.
To provide scope for further enrichment of HSCs and multipo-
tent HPCs, HC1 cells (Figure 3Ei) were index-sorted and
analyzed for single-cell CFU-C lineage output and G2, cKit,
and CD31 MFIs. A total of 86 CFU-Cs was obtained (plating ef-
ficiency, 1:9–11). Ninety-two percent (21% GEMMs + 71%
GMs) of the CFU-Cs were multipotent/bipotent (Figure 3Eii).
Cells yielding GEMMs showed significantly higher average
MFIs for G2 expression as compared to GM and G cells (Fig-
ure 3Eii). MFIs for cKit (Figure 3Eiii) and CD31 (Figure 3Eiv)
were not significantly different when GEMM and GM cells were
compared. Together, these data indicate that all HSCs and the
most multipotent HPCs are enriched within the CD31hiSSClo
cKithiG2med (HC1) fraction and that cells that produce GEMMs
had higher G2 MFIs as compared to the more widely varying
G2 MFIs for GM-producing cells.
Iterative Analyses Link Expression of Specific Genes
with HSC and Multipotent HPC Function
Gene lists were examined for new candidate markers of HC1
cells as compared to the other clusters (Table S1). Violin plots
showed significantly higher Tnfrsf7 (CD27) expression in HC1
(Figure 4A; Figure S2A), as well as Selp andMpl (Figure S2B). In-
dex-sorting parameters revealed that 70% of E11 CD31hi
SSClocKithiG2med (HC1) cells were CD27+ (Figure 4B). Using
this wide (+W) gate (MFI = 150–7,000), CD27+W cells were iso-
lated and transplanted into irradiated recipients. High-level,
long-term multilineage in vivo repopulation by the CD27+W HC1
donor cells was detected in 2 of 2 recipients (Figure 4C, open
squares). Secondary transplantations confirmed that these
were self-renewing HSCs (Figure S3A). For further enrichment,
a higher and narrower (+N) CD27 gate (MFI = 500–7,000) was
set (Figure 4B), and CD27+N (19%) andCD27/lo (81%) HC1 cells
were transplanted. The CD27+N HC1 cells yielded high-level,
long-term multilineage repopulation in both primary (Figure 4C,
black squares) and secondary (Figure S3A) transplantations.
No HSCs were found in the CD27/lo HC1 fraction, even with in-
jection of high numbers of cells. As compared to the CD31hi
SSClocKithiGata2med sorted fraction, the CD27+N gate enriches
HSCs by a further 5.2-fold.
Single-cell RNA-seq of 119 CD31hiSSClocKithiGata2med
CD27+N cells (from 6AGMs) was performed, and data were com-6 Cell Reports 31, 107627, May 12, 2020bined with the 968 cells to produce a new SPRING plot of 1,087
cells. Louvain clustering showed a cluster distribution (L2.1–
L2.12) of the 1,087 cells (Figures S3B and S3C) almost identical
to that obtained from the 968 cells (Figure S1Bi). The majority
(71%) of the 119 CD27+N cells (Figure 4D, red) localized to
HC1, and 58% localized to L2.8 (Figure 4D, circled).
Interestingly, when index-sorted CD27+N cells were analyzed
in single-cell CFU-C assays (plating efficiency, 1:3–4 cells),
GEMM-forming cells showed a significantly lower average
CD27 MFI (767.1 ± 41.8; Figure 4Ei) and a significantly higher
G2 MFI (1,022.0 ± 60.1; Figure 4Eii) than those of GM-forming
cells (945.2 ± 44.6 and 858.3 ± 31.8, respectively). Average
cKit and CD31 MFIs were not significantly different (Figures
4Eiii and 4Eiv). Notably, 95% of immature/HSC-like progenitors
forming GEMMs fall within the smaller CD27 MFI range of 513–
1,084 (Figure 4F, red dotted area), which is now referred to as
CD27med. The CD27med fraction is 15.5% ± 1.3% of HC1 and
86% of CD27+N cells. There are 20 ± 2 CD27med HC1 cells per
AGM, of which 1–2 were HSCs at the time of analysis. In addition
to our HC1 enrichment (10.5-fold), a further 6.5-fold enrichment
of HSCs was achieved in the CD27med fraction to yield a com-
bined enrichment of 68.3-fold (summarized in Figure 4G).
Defining the AGM HSC Transcriptome
The increased enrichment of multipotent cells within the
CD27med MFI range provided a means for dataset refinement
in which the molecular profiles of different functional subsets
could be examined. Out of the 119 CD31hiSSClocKithi
Gata2medCD27+N cells previously isolated for single-cell RNA-
seq (Figure 4D), 85 belonged to HC1, of which 14 showed
CD27hi and 71 CD27med expression. We analyzed the 85 cells
using Iterative Clustering and Guide-gene Selection (ICGS) (Ols-
son et al., 2016), which can define groups of genes that behave
similarly and identify groups of cells with similar gene-expression
patterns. Three groups of genes and 3 groups of cells that we
named ICGS1, ICGS2, and ICGS3 contained 54, 29, and 2 cells,
respectively (Figures S4 and S5). When the distribution of the
ICGS groups within the previously defined L2.7 and L2.8 clusters
was examined, 81% of the 85 CD27+N cells fell within L2.8, and
19% fell within L2.7. ICGS1 cells were mainly in L2.8, whereas
ICGS2 cells were equally distributed in L2.7 and L2.8, suggesting
that these cells are acquiring HSC identity. The hscScore for
each cell was calculated and plotted against its CD27 MFI value
(Figure 5A). ICGS2 cells were almost exclusively in the CD27med
and high hscScore range, whereas ICGS1 cells were within the
full CD27 MFI range and showed a low hscScore. Together,
these data confirm that ICGS2 cells are the most multipotent
or HSC-like.
To more precisely identify the transcriptome of the few HSCs
within the 85 cell profiles, other known HSC characteristics were
examined. Ly6a is known to be expressed by all in vivo adult re-
populating AGM HSCs (de Bruijn et al., 2002). Ly6a can be de-
tected in 27 of the 85 cells within HC1 (Figure 5Bi), 23 of 71
CD27med cells (Figure 5Bii), and 4 of 14 CD27hi cells (Figure 5Biii),
consistent with previous findings that Ly6a expression is not
exclusive to HSCs. We then focused our attention on the 23
Ly6a+ cells within the ‘‘multipotent/HSC’’ CD27med MFI range
(Figure 5C). These cells separated into two ICGSs: 15 belonged
Figure 4. All Functional AGM HSCs Are within the HC1 CD27med Fraction
(A) Violin plots of Tnfrsf7 (CD27) expression in the 5major transcriptomic clusters. EC, endothelial-like cluster; HC1, hematopoietic cluster 1; HC2, hematopoietic
cluster 2; UC1, unknown cluster 1; UC2, unknown cluster 2.
(B) Enrichment sorting parameters for CD27+ HC1 cell isolation. Side scatter (SSC-A), CD31, cKit, Gata2 (G2), and CD27 sorting gates and percentage (±SEM) of
cells. CD27+ cells (%) are indicated within a wide (+W) and a narrow (+N) mean fluorescent intensity (MFI) gate.
(C) Analysis of HSC function within CD27 fractions (CD27+W, CD27+N, and CD27/lo) of HC1 cells by in vivo transplantation. Open squares denote CD27+W HC1
cell recipients (n = 2) of 442 cells (2.5ee) and 479 cells (3.3 ee) from 15 and 9 (42–50 somite pairs, sp) embryos, respectively. Closed squares (n = 4; 42–49 sp;
embryos/experiment: 25, 11, 22, 28) denote recipients injected with CD27+N HC1 cells (238–957; 3.7–9.8 ee), EC cells (899–2,333; 3.9–8.6 ee), CD27-/lo HC1 cells
(1,042–4,325; 4.1-9.8 ee), and UC1+2+HC2 cells (1,361–3,741; 4.2–9.9 ee). Percentage of donor cell chimerism in peripheral blood of recipients at 4months post-
injection. Black line indicates mean.
(D) Single-cell RNA-seq of 119 CD31hiSSClocKithiGata2medCD27+N sorted cells (all passed quality control) from 6 embryos (41–47 sp). These data combined with
the previous dataset (gray) resulted in an extended dataset SPRING plot of 1,087 cells in total. Overlay of CD27+N cells (red) showing localization to one HC1
subcluster (circled).
(E) Single CD27+N HC1 cells from E11 G2V IAHCs (50 embryos; 42–49 sp) deposited into methylcellulose and colony-forming unit-culture (CFU-C) counts at
8–10 days (138 total CFU-Cs). Colony type (individual dot) plotted against log10-normalized mean fluorescence intensities (MFIs) for (Ei) CD27, (Eii) G2, (Eiii) cKit,
and (Eiv) CD31 expression. GEMM, granulocyte-erythroid-macrophage-megakaryocyte; GM, granulocyte-macrophage. Red lines indicate mean ± SEM.
(F) Representative FACS plot showing newly defined CD27med MFI range (red dotted line) within the CD27+N fraction. Percentage ±SEM.
(G) Summary of enrichment strategy. The HC1 fraction containing all HSCs is 10.5-fold enriched compared to previous sorting strategies (Eich et al., 2018).
Further enrichments are based on gating of specific CD27+N and CD27med fractions to give an additional 6.5-fold enrichment. After iterative analyses and
refinement of sorting gates, a total combined HSC enrichment of 68.3-fold is achieved.
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ICGS2 had the highest hscScores: 4 belonged to L2.7, and 4 be-
longed to L2.8. Thus, the stratified results of single-cell index-
sorting, transcriptome profiling, and functional analyses strongly
suggest a profile for HSCs that is unique but closely related to
that of multipotent HPCs.
Considering the expression of several genes relevant to
HSC generation, the profile for the 8 Ly6a+CD27med ICGS2
single cells stands out (Figure 5C). Notch pathway genes
(Bigas and Porcheri, 2018) are highly represented in thesecells and include Hes1 and Hey1 (negative regulators), Dll4
(Notch ligand), and Notch4. Sox17, which is known to be
expressed in fetal HSCs and maintain stem cell potency (He
et al., 2011), is highly expressed, as is Il6st, which is part of
the receptor complex for hematopoietic and stem cell factors
interleukin (IL)-6, leukemia inhibitory factor (LIF), and Oncosta-
tin M (Mihara et al., 2012). Also, Nos3 (endothelial nitric
oxide synthetase), which functions in AGM HSC and HP/SC
generation (North et al., 2009), is highly expressed. VEGF-R,
Flt1, and Kdr are expressed along with other HSC genesCell Reports 31, 107627, May 12, 2020 7
Figure 5. Defining the Transcriptome of the First Functional HSCs
(A) Plot of hscScore against CD27MFI for 85 CD31hiSSClocKithiGata2medCD27+N cells. Majority of ICGS2 cells (black) found in the CD27med and higher hscScore
range and ICGS1 cells (red) within the full CD27 MFI and mostly low hscScore range. ICGS3 cells are indicated in gray.
(B) Ly6a expression was plotted on the SPRING visualization of (Bi) 85 CD31hiSSClocKithiGata2medCD27+N cells, (Bii) 71 CD27med cells (CD27hi in green), and (Biii)
14 CD27hi cells (CD27med in green) within HC1 (gray).
(C) Replotting of 85-cell heatmap in Figure S4 (maintaining the same order and position) with subset of ICGS output (Figure S5) for the 23 Ly6a+CD27med cells
belonging to HC1 (L2.7+L2.8). 3 gene clusters (RowCluster) and 2 cell clusters (ICGS1 and ICGS2) can be defined. HscScore, log10 of the CD27 index-sorting
(protein) levels and Louvain identity (L2.7, L2.8) are also depicted.
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OPEN ACCESSsuch as Cdkn1c, Pdzk1ip1, Procr, Ramp2, Trim47, and Vwf.
Thus, the near-equivalence of the transcriptomic profiles of
the 8 Ly6a+CD27med ICGS2 cells provides a likely genetic
identity for the first cells achieving HSC function in the mouse
embryo.
Functional HSCs Are Localized in 1- to 2-Cell IAHCs
Having defined the transcriptome of functional HSCs, we
examined the localization of CD27-, Ly6a-, and Gata2-ex-
pressing cells within IAHCs. E11 G2V cryosections immuno-
stained for CD27 and CD34 showed rare G2+CD34+CD27+
cells almost exclusively within the smallest ventrally located
IAHCs. Figure 6A shows two CD34+G2+CD27+ cells (arrow-
head) attached to one CD34+G2+CD27 cell within the endo-
thelium, and a single rounded/bulging CD34+G2+CD27+ cell
(arrow). Another section shows a ventral cluster (Figure 6Bi)
with two CD34+G2medCD27+ cells (one appearing to be
bulging out of the endothelium) surrounded by 3–4
CD34+G2+CD27 cells. Also found ventrally (Figure 6Bii) was8 Cell Reports 31, 107627, May 12, 2020a 2-cell cluster with a single CD34+G2medCD27+ cell closely
associated with a CD34+G2loCD27 cell (Video S1). Fig-
ure 6Biii shows a single rounded bulging CD34+G2+CD27+
cell on the dorsal aspect of the aorta (likely an HPC; Taoudi
and Medvinsky, 2007). Examination of CD27+ cell-containing
IAHCs revealed that 80% (56 out of 70; 42 in 1-cell clusters
and 14 in 2-cell clusters; n = 4 embryos) were 1- to 2-cell clus-
ters (Figure S6). Since all HSCs and most multipotent progen-
itors are CD27+, we conclude that these functional cells are
localized closely to the ventral aortic endothelium within small
or single-cell IAHCs.
E11 Ly6aGFP transgenic embryo sections were also immu-
nostained to examine whether this HSC marker could subset
and/or provide further validation into the localization of
CD27+ HSCs. A single GFP+CD27+ cell was observed at the
apex of a bulging GFP+ cell within the ventral endothelium
(Figure 6Ci, arrowhead); another GFP+ cell (arrow) was
observed in the ventral endothelium, but it was CD27. Fig-
ure 6Cii indicates two round adjacent CD27+ cells, of which
Figure 6. Functional HSCs Are Localized in 1- to 2-Cell IAHC Cells
(A–D) Sections through dorsal aorta of E11 (43 somite pairs, sp) Gata2Venus (green in A and B) and Ly6aGFP (green in C) and of E10.5 (36sp) Csf1rGFP
(MacGreen; green in D) embryos. Nuclei are indicated in blue (DAPI), endothelial and IAHC cells are indicated in red (CD34) and CD27+ cells are indicated in white.
v, ventral, d, dorsal.
(A) Arrowhead indicates small cluster containing two G2+CD27+ cells attached to one G2+CD27 cell. Arrow indicates a single rounded/bulging G2+CD27+ cell.
(B) In (Bi), ventral cluster with twoG2medCD27+ cells (one bulging out of endothelium). (Bii) Ventral two-cell cluster (G2medCD27+ andG2loCD27 cells). (Biii) Single
rounded bulging G2+CD27+ cell on dorsal side of aorta.
(C) In (Ci), single Ly6aGFP+CD27+ cell (arrowhead) at apex of bulging Ly6aGFP+ cell within ventral endothelium. A neighboringGFP+ cell in the ventral endothelium
is CD27 (arrow). (Cii) Two round CD27+ cells (one is Ly6aGFPlo, indicated by arrowhead) adjacent to each other and attached to interspersed Ly6aGFP+
endothelium. (Ciii) Three CD27+ cells (indicated by arrowheads; one is Ly6aGFP+) in very close association with ventral endothelium.White dashed boxes indicate
magnified areas.
(D) One CD27+CD34+ cell on dorsal endothelial wall closely associated with a macrophage. White dashed box indicates area for which MacGreen and CD27
expression is shown.
Scale bars, 20 mm.
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endothelial cells. Three CD27+ cells, one of which is GFP+
(Figure 6Ciii, arrowheads), were found in very close associa-
tion with the ventral endothelium. The juxtaposition of single
CD27+Ly6aGFP+ cells to the ventral aortic endothelium indi-
cates that HSCs emerge directly from embryonic endothelium
as single cells within intra-aortic clusters of 1–2 cells.
DISCUSSION
Here, we identified the transcriptome of the first functional adult
repopulating HSCs. Starting from Gata2-based single-cell in-
dex-sorting and iterative single-cell analyses, the ‘‘inner’’ HSC
transcriptional regulatory network is connected directly with
multipotent hematopoietic function in vivo and in vitro. Specific
levels of Gata2, cKit, and CD27 expression define all functional
in vivo repopulating HSCs, and, together with Ly6aGFP expres-
sion, CD27 localizes the first HSC to the smallest intra-aortic
clusters of 1–2 cells. The surprising variability in gene expression
levels within highly enriched single cells suggests that establish-
ment of hematopoietic function is stochastic, occurring through
dynamic regulation and/or unstable expression of groups of
pivotal genes.Emerging HCs Are Heterogeneous in Phenotype,
Transcriptome, and Function
EHT occurs during a short 2- to 3-day period during mouse
midgestation (Yokomizo and Dzierzak, 2010; Zovein et al.,
2008) and extends over the length of the aorta to produce IAHCs
that are predominantly ventral (Peeters et al., 2009; Souilhol
et al., 2016; Taoudi and Medvinsky, 2007) and more abundant
near the juncture of the vitelline artery (Mascarenhas et al.,
2009). Individual intra-aortic clusters range from 1 to 19 cells at
E10.5 and from 1 to 11 cells at E11.5 (Yokomizo and Dzierzak,
2010). Single-cell quantitation of functional HPCs and HSCs
within the clusters shows that the number of lineage-restricted
HPCs is the highest, followed by that of multipotent HPCs and
rare HSCs. This low frequency of HSCs implies that stem cell
identity/function is a difficult hematopoietic fate to achieve.
Whereas all functional HSCs are in ventral clusters and near
the vitelline junction, it cannot be predicted which emerging
cell in the aorta is an HSC. The variability in phenotypic marker
expression, and the degree of heterogeneity found in the tran-
scriptomes of individual cells during the embryonic development
of HPCs, pre-HSCs, andHSCs (Zhou et al., 2016), has precluded
the identification of the transcriptome of rare HSCs. Rather than
dependence on surface molecules not required for HSCCell Reports 31, 107627, May 12, 2020 9
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with the ‘‘inner’’ hematopoietic regulatory network. G2medCD31hi
cKithi cells highly enriched inmultipotent HPCs and containing all
functional repopulating HSCs show unexpected heterogeneity
between single-cell transcriptomic profiles. Louvain analysis of
>1,000 sequenced cells revealed 5 major cell clusters. Unex-
pectedly, within this highly enriched set of IAHC cells, one major
cluster still expressed endothelial markers and was deemed
endothelial-like (an EC). Surprisingly, it did not express Runx1.
The second major cluster exhibited a hematopoietic gene-
expression profile, and other minor clusters showed mixed or
mature HC profiles.
Considering that the G2medCD31hicKithi fraction contains a
high frequency of multipotent HPC and HSC activity, it begs
the question whether the EC and/or the other minor cell clus-
ters possess some degree of hematopoietic identity but either
are not yet functional or are the predecessors of HPCs and
HSCs. Data from several laboratories have described embry-
onic HCs lacking HSC activity and have shown that these cells
can exhibit HSC function after in vitro culturing (Ganuza et al.,
2017a; Rybtsov et al., 2016) or neonatal transplantation (Yoder
et al., 1997), perhaps by stabilization of a genetic program.
While some of these cells could represent pre-HSCs, others
could be products of EHT that never successfully achieve
HSC function. They may be in a ‘‘neutral’’ or ‘‘naive’’ state
awaiting establishment of another functional hematopoietic
identity, perhaps to a multipotent progenitor that others have
shown to maintain steady-state hematopoiesis (Busch et al.,
2015; Pei et al., 2017; Rodriguez-Fraticelli et al., 2018; Schoe-
del et al., 2016; Sun et al., 2014).
Heptad Factors and Gata2 Heterogeneous Expression
We discovered variability in the expression levels of the he-
matopoietic heptad TFs in the clusters. The requirements for
Gata2, Runx1, and other heptad TFs Lmo2, Fli1/Erg, and
Tal/Lyl1 in EHT and HSC generation (Chen et al., 2009; de
Pater et al., 2013) have been extensively demonstrated in
the mouse embryo (Dzierzak and Speck, 2008). The TFs
work in a combinatorial manner to activate transcription of
downstream hematopoietic effector genes (Pimanda and
Go¨ttgens, 2010; Wilson et al., 2010). Whereas the single hap-
loinsufficient state of Gata2 and Runx1 affects HC develop-
ment, the double haploinsufficiency of these TFs has more
profound effects (Wilson et al., 2010), indicating the exquisite
sensitivity of hematopoietic development to combinatorial TF
levels.
The fact that, within the highly enriched IAHC fraction, the EC
was negative for Runx1 expression and UC1 was negative for
Gata2 expression indicates that TF level changes may result in
non-functional HCs. However, it is important to note that
Runx1- and Gata2-deleted embryos still produce some func-
tional HCs (Kaimakis et al., 2016; Tsai et al., 1994; Wang et al.,
1996), suggesting that there is more than one way to make a
HC. The absence of complex definitive hematopoietic activity
in such embryos confirms the pivotal role of these TFs in the gen-
eration of functional HSCs.
When linked to the recently demonstrated pulsatile expres-
sion of Gata2 in cells undergoing EHT (Eich et al., 2018), a dy-10 Cell Reports 31, 107627, May 12, 2020namic combinatorial TF code may affect hematopoietic fate
and function acquisition in individual cells. For example asyn-
chronous fluctuations of levels of several TFs (due to tran-
scriptional pulsing, protein processing, and/or half-life) could
result in a variety of different molecular states, as shown in
T cells (Kueh et al., 2016). Only when a sweet spot of combi-
natorial factor levels is reached within a single cell will HSC or
HPC identity and function be achieved. This would be consis-
tent with the low frequency of HSCs (1–2 HSCs/~700 cluster
cells) and the higher frequency of HPCs (350/~700) found in
the in vivo E10.5 aorta at the time of embryo isolation. It
also could explain why the simple combined transduction
and overexpression of TFs in reprogramming experiments
does not robustly induce the transition to HSC fate (Dzierzak
and Bigas, 2018).
Novel Combinations of Iterative Single-Cell Methods
Identify the HSC Transcriptome
Iterative single-cell RNA-seq, index-sorting, functional ana-
lyses, and bioinformatics led us to progressively higher en-
richments of HSCs. Several putative HSC markers were iden-
tified within the HC1 single-cell transcriptomes and included
CD27, Selp/P-selectin, and Mpl. Expression level distribution
of single cells in Louvain clusters indicated that CD27 and
Selp were likely to be most useful. Previously, CD27 was re-
ported to be expressed on bone marrow (Vazquez et al.,
2015) and AGM HSCs (Li et al., 2017). Although CD27 is not
exclusive to HSCs (and is expressed by some cells in the
EC Louvain cluster), we discovered that cells expressing spe-
cific medium levels of CD27 within the G2medSSCloCD31hi
cKithi fraction yielded a further 6.5-fold enrichment on top of
the HC1-only enrichment. While multipotent/bipotent HPCs
were also enriched in this CD27med fraction, all unipotent
HPCs were absent. As Selp is most prominently expressed
by HC1 cells, it also could offer an opportunity for further
enrichment of aortic HSCs (Sullivan et al., 2011). Finally,
Mpl, the receptor for thrombopoietin is known to regulate
the generation and self-renewal of AGM HSCs (Petit-Cocault
et al., 2007). Together, these markers offer additional opportu-
nities for the isolation/identification of single functional HSCs
as they are first generated in the embryo.
Stratifications of single-cell transcriptomic data revealed the
expression of a combination of other genes expressed by func-
tional HSCs. These include Ly6a, DLL4, Sox17, and eNOS, as
well as others. Ly6aGFP has been shown to be expressed on
all AGM HSCs (de Bruijn et al., 2002; Solaimani Kartalaei et al.,
2015); DLL4 is involved in arterial endothelial identity and, most
recently, has been shown to govern the dynamics of cluster for-
mation and HSC production (Bonkhofer et al., 2019; Gama-Nor-
ton et al., 2015; Porcheri et al., 2020); Sox17 maintains stem cell
potency (He et al., 2011); and the deficiency of eNOS affects the
development of IAHCs and functional HSCs (North et al., 2009).
The fact that the combined expression of these genes occurs in
the 8 cells within the 119 sequenced G2medSSCloCD31hi
cKithiCD27+N single cells (isolated from 6 embryos) has impor-
tant implications for understanding the regulation of HSC fate/
function establishment and provides a useful reference for the
ex vivo generation and/or growth of HSCs.
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Ventral Aortic Clusters
Since HSC fate acquisition is rare, there has been much specu-
lation on the specific localization of HSCs within the IAHCs. Do
they take onHSC fate immediately upon emergence from the he-
mogenic endothelium, or do they emerge as pre-HSCs? Do they
emerge as a single cell and remain as a 1-cell cluster, or are they
within larger clusters of proliferative cells?
Time-lapse imaging of the zebrafish and mouse embryonic
aorta proved that the AGM region is a HC-generative niche
(Bertrand et al., 2010; Boisset et al., 2010; Kissa and Herbomel,
2010). Single HCs emerge directly from ventral aortic endothe-
lial cells, and results of genetic studies support that at least
some of the cells taking on hematopoietic identity are func-
tional HSCs. Here, by co-expression of CD27 and Ly6aGFP,
we show the localization of HSCs to the small 1- to 2-cell aortic
clusters. Additionally, our RNA-seq data show DLL4 expression
in the single HSC profiles, whereas the other single G2med
SSCloCD31hicKithiCD27+N aortic cells are DLL4 negative/low.
These results are in agreement with a recent study showing
that, in the absence of DLL4, larger and more abundant aortic
clusters are established (Porcheri et al., 2020), and, together,
they suggest that DLL4 may be maintaining HSC quiescence
and/or function.
Finally, we observed single MacGreen+ macrophages
interacting with single aortic CD27+ (Figure 6D) and Ly6a+
emerging cells (Mariani et al., 2019). The presence of these
macrophages in the AGM enhances HSC and HPC output
(Mariani et al., 2019) and further reinforces the notion
that intersecting multiple signals are needed for establishing
HSC fate identity and function in single emerging cells. In
conclusion, the iterative approaches used in our study
have enabled the correspondence of single-cell transcrip-
tomic profiles with the first functional HSCs generated in
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Mouse models
All mice were housed and bred in animal facilities at the University of Edinburgh, in compliance with UK Home Office regulations. All
animal experiments were conducted according to a UK Home Office Project License (PPL 70/8076 and continuation PC6D479E0)
and approved by the University of Edinburgh Ethical Review Committee.
Adult C57BL/6JOlaHsd (Ly5.2) wild-type females were obtained from Envigo (order code: 057) and used at 2-4 months old.
Gata2V/V (Kaimakis et al., 2016), Ly6aGFP+/ (de Bruijn et al., 2002) and Csf1rGFP+/ (MacGreen, (Sasmono et al., 2003) males
(> 10 backcrosses onto C57BL/6JOlaHsd) were used at 2-12 months old.
All transplantations were with 2-4 months old B6.SJL-PtprcaPepcb/BoyCrl (Ly5.1/5.1; Charles River; strain code: 494) recipients
(males and females mixed).
METHOD DETAILS
Mouse embryo generation
Gata2V/+, Ly6aGFP+/ and Csf1rGFP+/ embryos were generated by timed matings of C57BL/6JOlaHsd wild-type females with
Gata2V/V, Ly6aGFP+/ and Csf1rGFP+/ males respectively. Genotyping was performed by Venus or GFP fluorescence screening
of the placenta or embryonic tail. Day of plug discovery was embryonic day (E)0 and staging was by somite pair (sp) counts
(E10 = 30-39sp; E11 = 40-49sp).
Preparation of AGM single cell suspensions for flow cytometry
AGM (aorta-gonad-mesonephros) regions (including trunk portion of the vitelline and umbilical arteries) of E10/11 embryos were
dissected as previously described (Medvinsky et al., 2008). Single cell suspensions were prepared by enzymatically digesting tissues
at 37C in 0.125% type 1 collagenase (C0130, Sigma-Aldrich) for 45min, after which tissues were further mechanically disrupted with
a P1000 pipette. Cells were subsequently passed over a 0.35 mm strainer, collagenase washed away with PBS+10%FBS+1%P/S
(PFP), spun down (234g) and resuspended in PFP for flow cytometric antibody staining. Cells were incubated at 4C for 30 min in
PFP with directly conjugated antibodies against CD31 (CD31-BV605, 1:100, cat# 102427, Biolegend), cKit (cKit-BV421, 1:200,
cat.# 562609, BD) and CD27 (CD27-APC, 1:75, cat.# 17-0271-82. eBioscience). Excess of antibodies was washed away with
PFP before fluorescence activated cell sorting (FACS) on an AriaII (BD). Dead cell exclusion was by Hoechst 33342 and gates
were set based on unstained WT and fluorescence-minus-one (FMO) controls. Sorted single cells were collected in 50% FBS/
PBS for functional analyses (transplantation + bulk CFU-C assay). Both collagenase and FCS were batch tested for optimal AGM
conditions.
Hematopoietic stem cell transplantation and (single-cell) CFU-C assay
For transplantation, sorted cell populations (Ly5.2/CD45.2 background) were resuspended in PBS together with 2x105 Ly5.1 spleen
carrier cells and intravenously injected into irradiated Ly5.1 (CD45.1) recipients that had received two split-doses of 4.5Gy (Cs-137Ɣ-
irradiator). Peripheral blood was sampled for CD45.1- and CD45.2 flow cytometric analysis at 4 and 16 weeks post-transplantation.
Mice were considered repopulated with long-term reconstituting cells atR 5%donor chimerism. For population/bulk CFU-C assays,
sorted cells were resuspended and cultured in Methylcellullose medium (M3434; StemCell Technologies) in a humidified chamber at
37C and 5%CO2 for 9-11 days after which colonies were counted. For single-cell CFU-C assays, cells were sorted directly into 96-
well plates with one (P1000) drop ofMethylcellulosemedium deposited per well and cultured and counted under the same conditions
as for population CFU-C assays.
Immunohistochemistry on cryosections
Gata2V/+ and Ly6aGFP+/ and MacGreen+/ embryos were staged and fixed in 2% PFA/PBS for 1 hr and quickly washed in PBS.
Embryos were then equilibrated overnight (O/N) in 20% sucrose/PBS at 4C, after which they were washed in Tissue-Tek O.C.T.
embedding matrix (Sakura). Tissue paper was used to remove remaining sucrose and each embryo was placed in an individual
mold filled with embedding matrix. Forelimbs were orientated exactly above hind limbs before being frozen on dry ice in absolute
ethanol. 10 mm transversal cryosections were cut through the AGM region and collected on Superfrost Plus slides (Thermo Fisher
Scientific). For immunohistochemistry, sections were fixed for 10 mins with acetone, washed three times with 0.05% Tween20/
PBS (PBST) and then blocked with a 1:1 mixture of Streptavidin solution (Vector Laboratories Inc) and PBSblock (0.05% Tween20,
1% bovine serum albumin/PBS) for 15 mins. After three PBST washes, slides were incubated with Biotin solution (Vector Labora-
tories Inc) for 15 mins and washed another three times in PBST. Sections were incubated with rat anti-mouse-CD34-biotin (1:100,
13-0341-82, eBioscience), rabbit anti-GFP (1:1000, 598, MBL) and Armenian hamster anti-mouse-CD27 (1:100, 14-0271-82, eBio-
science) diluted in PBSblock for 1hr at RT. Unbound primary antibodies were washed away with PBST after which sections were
incubated with Streptavidin-AlexaFluor555 (1:500, S21381, Invitrogen), anti-rabbit AlexaFluor488 (1:500, A11008, Invitrogen) and
anti-Armenian hamster AlexaFluor647 (1:500, 405510, Biolegend) diluted in PBSblock for 30 mins at RT. Slides were washed three
times in PBST and incubated in DAPI (1:1000) diluted in PBSblock for 10mins at RT. Afterward, slides werewashed once in PBST ande3 Cell Reports 31, 107627, May 12, 2020
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SP8 confocal microscope and images and videos generated with the LAS X software (Leica).
Single-cell RNA sequencing
Cells were sorted in 2.3 ml of lysis buffer containing 0.2% Triton X-100 (Sigma-Aldrich) and 1U of Superase-In RNase Inhibitor (Am-
bion) and processed following the Smart-Seq2 protocol (Picelli et al., 2014) Following preamplification, all samples were purified us-
ing Ampure XP beads (Beckman Coulter) at a ratio of 1:0.6. The cDNA was then quantified using the Quant-iT PicoGreen dsDNA
Assay Kit (Thermo Fisher) and size distributions were checked on high-sensitivity DNA chips (Agilent Bioanalyzer). Samples were
used to construct Nextera XT libraries (Illumina) from 125 pg of preamplified cDNA. Libraries were purified and size selected
(0.5X-0.7X) using Ampure XP beads. Then, libraries were quantified using KAPA qPCR quantification kit (KAPA Biosystems), pooled
and sequenced in an Illumina HiSeq 4000 instrument.
Bioinformatic Analysis
Reads were mapped to a custom reference index that included theMusmusculus genome (EMSEMBLGRCm38.p4 Release 81) and
the sequences of ERCC spike-ins (Life Technologies), IRES and Venus using GSNAP (version 2014-10-07) (Wu et al., 2016) with pa-
rameters: -A sam –B 5 –t 24 –n 1 –Q –N 1. HTseq-count was used to count reads mapped to each gene with parameters: –s no (An-
ders et al., 2015). For further analyses, we only retained samples that had: (1) more than 100,000 readsmapped to nuclear mRNAs; (2)
a proportion of reads mapped to genes (nuclear + mitochondrial) relative to total reads above 30%; and (3) less than 20% of mapped
reads allocated tomitochondrial genes. Overall, 47 cells (4.1% of total) failed the QC under those criteria and 1087 cells were kept for
further analysis distributed as follows: 87 E10 CD31+cKithiG2int cells, 409 E11 CD31+cKithiG2int cells, 472 E11 CD31+cKithiG2lo cells
and 119 E11 CD31hiSSClocKithiG2medCD27+N cells. The mean of nuclear reads mapped per cell was 1,213,237. Data were normal-
ized for sequencing depth and RNA quantity using size factors calculated on endogenous genes (Brennecke et al., 2013). Highly var-
iable genes were identified as previously described (Brennecke et al., 2013), using a false discovery rate threshold equal to 0.1. Only
highly variable genes were considered to perform PCA analysis, using the prcomp function in R. SPRING visualization (Weinreb et al.,
2018) and was obtained using the top 90 principal components and the 4 nearest neighbors. Clusters were defined using the clus-
ter_louvain function in R igraph package. Violinplots were obtained using the ggplot2 package in R. hscScores were calculated as
previously described (Hamey and Go¨ttgens, 2019). Differential expression analysis was performed using DESeq2 (Love et al., 2014).
CD27+ cells (Protein level) was extracted from HSC clusters (clusters L2.7 and L2.8). In total, there are 85 cells, with 4445 highly
variable genes selected. Highly variable genes were used for ICGS clustering (AltAnalyzer (Olsson et al., 2016)) with ‘stringent’ with
cell cycle and all other parameters as default.
For integration with previously published dataset (Zhou et al., 2016), the data was downloaded from GEO repository (GSE67120)
and processed as indicated above. Differential expression analysis was performed between either endothelial cells or pre-HSCs
(including T1 and T2) or HSCs (including E12 and E14) and the remaining cells to obtain cell type specific genes using DESeq2.
Only genes with log2 fold change > 2, adjusted p value (BH method) < 0.1 and base mean > 50 were used for further analysis.
Only the top 30 upregulated genes were selected to use in the heatmap.
QUANTIFICATION AND STATISTICAL ANALYSIS
All graphs were generated using GraphPad Prism 7. We performed Bartlett’s test for homogeneity of variances to ensure
variances for all samples were equal. With the assumption of normality, the data were compared for the same means using one-
way ANOVA, followed by a pairwise comparison using a Student’s t test, and Bonferroni correction. Significance was determined
as p < 0.05. *p < 0.05, **p < 0.01, ***p < 0.001. FACS percentages, averages (mean; red horizontal lines in Figures 1C, 1D, 3E,
and 4E) and error bars are ± standard error of the mean (SEM). Further statistical details of experiments can be found in the figure
legends. The number of biological replicates is indicated with ‘n’.Cell Reports 31, 107627, May 12, 2020 e4
